Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Julie A. Panepinto MD, MSPH

Julie A. Panepinto MD, MSPH

Professor

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology/Oncology
Program: Hematology

Member of the Cancer Center
Member of the Center For Patient Care and Outcomes Research (PCOR)


I am willing to mentor a junior faculty member.


Clinical Expertise

  • Anemia, Sickle Cell
  • Hematology
  • Publications

  • A multi-center randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. (Brousseau DC, Scott JP, Badaki-Makun O, Darbari DS, Chumpitazi CE, Airewele GE, Ellison AM, Smith-Whitley K, Mahajan P, Sarnaik SA, Casper TC, Cook LJ, Dean JM, Leonard J, Hulbert ML, Powell EC, Liem RI, Hickey R, Krishnamurti L, Hillery CA, Nimmer M, Panepinto JA) Blood 2015 Jul 31: PMID: 26232172 08/02/2015
  • Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature. (Brandow AM, Farley RA, Panepinto JA) Pediatr Blood Cancer 2015 Sep;62(9):1501-11 PMID: 25976161 PMCID: PMC4515148 05/16/2015
  • Five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA) Hematology Am Soc Hematol Educ Program 2014 Dec 5;2014(1):599-603 PMID: 25696917 02/20/2015
  • A Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease: Visual Analog Scale Versus Numeric Rating Scale. (Myrvik MP, Drendel AL, Brandow AM, Yan K, Hoffmann RG, Panepinto JA) J Pediatr Hematol Oncol 2015 Apr;37(3):190-4 PMID: 25575295 01/13/2015
  • Five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA) Blood 2014 Dec 4;124(24):3524-8 PMID: 25472968 12/05/2014
  • Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy. (Beverung LM, Strouse JJ, Hulbert ML, Neville K, Liem RI, Inusa B, Fuh B, King A, Meier ER, Casella J, DeBaun MR, Panepinto JA, SIT trial investigators) Am J Hematol 2015 Feb;90(2):139-43 PMID: 25345798 PMCID: PMC4304929 10/28/2014
  • The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay. (Brandow AM, Farley RA, Dasgupta M, Hoffmann RG, Panepinto JA) J Pediatr Hematol Oncol 2015 Jan;37(1):10-5 PMID: 25222053 PMCID: PMC4270887 09/16/2014
  • Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. (DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF) N Engl J Med 2014 Aug 21;371(8):699-710 PMID: 25140956 PMCID: PMC4195437 08/21/2014
  • Silent cerebral infarction, income, and grade retention among students with sickle cell anemia. (King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR) Am J Hematol 2014 Oct;89(10):E188-92 PMID: 25042018 PMCID: PMC4261188 07/22/2014
  • Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease. (Beverung LM, Varni JW, Panepinto JA) J Pediatr Hematol Oncol 2015 Mar;37(2):128-33 PMID: 24942019 PMCID: PMC4269583 06/20/2014
  • Ambulatory quality indicators to prevent infection in sickle cell disease. (Beverung LM, Brousseau D, Hoffmann RG, Yan K, Panepinto JA) Am J Hematol 2014 Mar;89(3):256-60 PMID: 24779032 PMCID: PMC4450348 04/30/2014
  • Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease. (Wiczling P, Liem RI, Panepinto JA, Garg U, Abdel-Rahman SM, Kearns GL, Neville KA) J Clin Pharmacol 2014 Sep;54(9):1016-22 PMID: 24729271 04/15/2014
  • Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. (Badaki-Makun O, Scott JP, Panepinto JA, Casper TC, Hillery CA, Dean JM, Brousseau DC, Pediatric Emergency Care Applied Research Network (PECARN) Magnesium in Sickle Cell Crisis (MAGiC) Study Group) Pediatr Blood Cancer 2014 Jun;61(6):1049-54 PMID: 24443249 PMCID: PMC3995128 01/21/2014
  • Neuropathic pain in patients with sickle cell disease. (Brandow AM, Farley RA, Panepinto JA) Pediatr Blood Cancer 2014 Mar;61(3):512-7 PMID: 24167104 PMCID: PMC4357477 10/30/2013
  • PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity. (Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW) Pediatr Blood Cancer 2014 Jan;61(1):171-7 PMID: 24038960 PMCID: PMC3848797 09/17/2013
  • Academic attainment findings in children with sickle cell disease. (Epping AS, Myrvik MP, Newby RF, Panepinto JA, Brandow AM, Scott JP) J Sch Health 2013 Aug;83(8):548-53 PMID: 23834606 07/10/2013
  • Clinically meaningful measurement of pain in children with sickle cell disease. (Myrvik MP, Brandow AM, Drendel AL, Yan K, Hoffmann RG, Panepinto JA) Pediatr Blood Cancer 2013 Oct;60(10):1689-95 PMID: 23776145 PMCID: PMC3993972 06/19/2013
  • Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion. (Collins CL, Scott JP, Panepinto JA, Punzalan RC) J Pediatr Hematol Oncol 2013 Jul;35(5):e226-8 PMID: 23459377 PMCID: PMC4508016 03/06/2013
  • Assessment of communication modes in patients and families with sickle cell disease. (Anderson C, Torres S, Gokuli S, Brandow AM, Panepinto JA) Pediatr Blood Cancer 2013 May;60(5):887 PMID: 23450782 03/02/2013
  • PedsQL™ sickle cell disease module: feasibility, reliability, and validity. (Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW) Pediatr Blood Cancer 2013 Aug;60(8):1338-44 PMID: 23441057 PMCID: PMC4412167 02/27/2013
  • What is the evidence that hydroxyurea improves health-related quality of life in patients with sickle cell disease? (Darbari DS, Panepinto JA) Hematology Am Soc Hematol Educ Program 2012;2012:290-1 PMID: 23233594 12/13/2012
  • Health-related quality of life in patients with hemoglobinopathies. (Panepinto JA) Hematology Am Soc Hematol Educ Program 2012;2012:284-9 PMID: 23233593 12/13/2012
  • Mental health disorders influence admission rates for pain in children with sickle cell disease. (Myrvik MP, Burks LM, Hoffman RG, Dasgupta M, Panepinto JA) Pediatr Blood Cancer 2013 Jul;60(7):1211-4 PMID: 23151972 11/16/2012
  • Patients with sickle cell disease have increased sensitivity to cold and heat. (Brandow AM, Stucky CL, Hillery CA, Hoffmann RG, Panepinto JA) Am J Hematol 2013 Jan;88(1):37-43 PMID: 23115062 PMCID: PMC3552380 11/02/2012
  • Health-related quality of life in sickle cell disease: past, present, and future. (Panepinto JA, Bonner M) Pediatr Blood Cancer 2012 Aug;59(2):377-85 PMID: 22522407 04/24/2012
  • Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S) Biol Blood Marrow Transplant 2012 Aug;18(8):1265-72 PMID: 22343376 PMCID: PMC3618440 02/22/2012
  • Inpatient management of sickle cell pain: a 'snapshot' of current practice. (Miller ST, Kim HY, Weiner D, Wager CG, Gallagher D, Styles L, Dampier CD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN)) Am J Hematol 2012 Mar;87(3):333-6 PMID: 22231150 01/11/2012
  • Concentration of hospital care for acute sickle cell disease-related visits. (Panepinto JA, Owens PL, Mosso AL, Steiner CA, Brousseau DC) Pediatr Blood Cancer 2012 Oct;59(4):685-9 PMID: 22180290 PMCID: PMC3310931 12/20/2011
  • Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. (DeBaun MR, Sarnaik SA, Rodeghier MJ, Minniti CP, Howard TH, Iyer RV, Inusa B, Telfer PT, Kirby-Allen M, Quinn CT, Bernaudin F, Airewele G, Woods GM, Panepinto JA, Fuh B, Kwiatkowski JK, King AA, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Sabio H, Gonzalez CE, Saccente SL, Kalinyak KA, Strouse JJ, Fixler JM, Gordon MO, Miller JP, Noetzel MJ, Ichord RN, Casella JF) Blood 2012 Apr 19;119(16):3684-90 PMID: 22096242 PMCID: PMC3335377 11/19/2011
  • Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. (Brandow AM, Panepinto JA) Am J Hematol 2011 Sep;86(9):804-6 PMID: 21815183 PMCID: PMC3804029 08/05/2011
  • When children with sickle-cell disease become adults: lack of outpatient care leads to increased use of the emergency department. (Hemker BG, Brousseau DC, Yan K, Hoffmann RG, Panepinto JA) Am J Hematol 2011 Oct;86(10):863-5 PMID: 21815184 08/05/2011
  • Development of the PedsQL™ Sickle Cell Disease Module items: qualitative methods. (Panepinto JA, Torres S, Varni JW) Qual Life Res 2012 Mar;21(2):341-57 PMID: 21638090 PMCID: PMC3277645 06/04/2011
  • Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. (Thornburg CD, Calatroni A, Panepinto JA) J Pediatr Hematol Oncol 2011 May;33(4):251-4 PMID: 21516020 PMCID: PMC3729442 04/26/2011
  • Outpatient follow-up and rehospitalizations for sickle cell disease patients. (Leschke J, Panepinto JA, Nimmer M, Hoffmann RG, Yan K, Brousseau DC) Pediatr Blood Cancer 2012 Mar;58(3):406-9 PMID: 21495162 04/16/2011
  • The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations. (Brandow AM, Weisman SJ, Panepinto JA) Pediatr Blood Cancer 2011 May;56(5):789-93 PMID: 21370412 PMCID: PMC3069506 03/04/2011
  • Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. (Brandow AM, Panepinto JA) Expert Rev Hematol 2010 Jun;3(3):255-60 PMID: 21082977 PMCID: PMC3793890 11/19/2010
  • Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. (Hulbert ML, McKinstry RC, Lacey JL, Moran CJ, Panepinto JA, Thompson AA, Sarnaik SA, Woods GM, Casella JF, Inusa B, Howard J, Kirkham FJ, Anie KA, Mullin JE, Ichord R, Noetzel M, Yan Y, Rodeghier M, Debaun MR) Blood 2011 Jan 20;117(3):772-9 PMID: 20940417 PMCID: PMC3035071 10/14/2010
  • Transition From Pediatric to Adult Care for Patients With Sickle Cell Disease-Reply. (Brousseau DC, Panepinto JA, Steiner CA) JAMA 2010 Jul 28;304(4):408-409 PMID: 22618679 07/28/2010
  • Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization. (Brandow AM, Jirovec DL, Panepinto JA) Am J Hematol 2010 Aug;85(8):611-3 PMID: 20658592 PMCID: PMC2911651 07/27/2010
  • The effect of parental mental health on proxy reports of health-related quality of life in children with sickle cell disease. (Panepinto JA, Hoffmann RG, Pajewski NM) Pediatr Blood Cancer 2010 Oct;55(4):714-21 PMID: 20589646 PMCID: PMC3835190 07/01/2010
  • Acute care utilization and rehospitalizations for sickle cell disease. (Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA) JAMA 2010 Apr 7;303(13):1288-94 PMID: 20371788 04/08/2010
  • The number of people with sickle-cell disease in the United States: national and state estimates. (Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG) Am J Hematol 2010 Jan;85(1):77-8 PMID: 20029951 12/24/2009
  • Vaso-occlusive painful events in sickle cell disease: impact on child well-being. (Brandow AM, Brousseau DC, Pajewski NM, Panepinto JA) Pediatr Blood Cancer 2010 Jan;54(1):92-7 PMID: 19653296 PMCID: PMC3114448 08/05/2009
  • A psychometric evaluation of the PedsQL Family Impact Module in parents of children with sickle cell disease. (Panepinto JA, Hoffmann RG, Pajewski NM) Health Qual Life Outcomes 2009;7:32 PMID: 19371442 PMCID: PMC2678996 04/18/2009
  • Dissatisfaction with hospital care for children with sickle cell disease not due only to race and chronic disease. (Brousseau DC, Mukonje T, Brandow AM, Nimmer M, Panepinto JA) Pediatr Blood Cancer 2009 Aug;53(2):174-8 PMID: 19350642 04/08/2009
  • Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events. (Brandow AM, Brousseau DC, Panepinto JA) Br J Haematol 2009 Mar;144(5):782-8 PMID: 19055663 PMCID: PMC3118502 12/06/2008
  • Impact of family income and sickle cell disease on the health-related quality of life of children. (Panepinto JA, Pajewski NM, Foerster LM, Sabnis S, Hoffmann RG) Qual Life Res 2009 Feb;18(1):5-13 PMID: 18989755 PMCID: PMC2840660 11/08/2008
  • The performance of the PedsQL generic core scales in children with sickle cell disease. (Panepinto JA, Pajewski NM, Foerster LM, Hoffmann RG) J Pediatr Hematol Oncol 2008 Sep;30(9):666-73 PMID: 18776758 PMCID: PMC2667700 09/09/2008
  • Parental perception of quality of hospital care for children with sickle cell disease. (Kam J, Panepinto JA, Brandow AM, Brousseau DC) WMJ 2008 May;107(3):131-5 PMID: 18575097 06/26/2008
  • Health-related quality of life in sickle cell disease. (Panepinto JA) Pediatr Blood Cancer 2008 Jul;51(1):5-9 PMID: 18338399 03/14/2008
  • The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis. (Brousseau DC, McCarver DG, Drendel AL, Divakaran K, Panepinto JA) J Pediatr 2007 Jun;150(6):623-6 PMID: 17517247 PMCID: PMC1978168 05/23/2007
  • Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay. (Goers T, Panepinto J, Debaun M, Blinder M, Foglia R, Oldham KT, Field JJ) Pediatr Blood Cancer 2008 Mar;50(3):603-6 PMID: 17480009 05/08/2007
  • Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. (Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA, Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A, Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research) Br J Haematol 2007 Jun;137(5):479-85 PMID: 17459050 04/27/2007
  • Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemia. (Hulbert ML, Scothorn DJ, Panepinto JA, Scott JP, Buchanan GR, Sarnaik S, Fallon R, Chu JY, Wang W, Casella JF, Resar L, Berman B, Adamkiewicz T, Hsu LL, Smith-Whitley K, Mahoney D, Woods G, Watanabe M, DeBaun MR) J Pediatr 2006 Nov;149(5):710-2 PMID: 17095350 11/11/2006
  • Attitudes regarding fertility preservation in female adolescent cancer patients. (Burns KC, Boudreau C, Panepinto JA) J Pediatr Hematol Oncol 2006 Jun;28(6):350-4 PMID: 16794502 06/24/2006
  • The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease. (Pawar SS, Panepinto JA, Brousseau DC) Pediatr Blood Cancer 2008 Jan;50(1):111-3 PMID: 16619223 04/19/2006
  • Perioperative management of sickle cell disease children undergoing adenotonsillectomy. (Duke RL, Scott JP, Panepinto JA, Flanary VA) Otolaryngol Head Neck Surg 2006 Mar;134(3):370-3 PMID: 16500429 02/28/2006
  • Acute idiopathic thrombocytopenic purpura of childhood-diagnosis and therapy. (Panepinto JA, Brousseau DC) Pediatr Emerg Care 2005 Oct;21(10):691-5; quiz 696-8 PMID: 16215478 10/11/2005
  • Health-related quality of life in children with sickle cell disease: child and parent perception. (Panepinto JA, O'Mahar KM, DeBaun MR, Loberiza FR, Scott JP) Br J Haematol 2005 Aug;130(3):437-44 PMID: 16042695 07/27/2005
  • Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. (Panepinto JA, Brousseau DC, Hillery CA, Scott JP) Pediatr Blood Cancer 2005 Feb;44(2):182-6 PMID: 15390359 09/25/2004
  • The effect of magnesium on length of stay for pediatric sickle cell pain crisis. (Brousseau DC, Scott JP, Hillery CA, Panepinto JA) Acad Emerg Med 2004 Sep;11(9):968-72 PMID: 15347549 09/07/2004
  • Validity of the child health questionnaire for use in children with sickle cell disease. (Panepinto JA, O'Mahar KM, DeBaun MR, Rennie KM, Scott JP) J Pediatr Hematol Oncol 2004 Sep;26(9):574-8 PMID: 15342984 09/03/2004
  • Pathophysiology of stroke in sickle cell disease. (Hillery CA, Panepinto JA) Microcirculation 2004 Mar;11(2):195-208 PMID: 15280092 07/29/2004
  • Clinical features of a human Rac2 mutation: a complex neutrophil dysfunction disease. (Kurkchubasche AG, Panepinto JA, Tracy TF Jr, Thurman GW, Ambruso DR) J Pediatr 2001 Jul;139(1):141-7 PMID: 11445809 07/11/2001
  • Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. (Ambruso DR, Knall C, Abell AN, Panepinto J, Kurkchubasche A, Thurman G, Gonzalez-Aller C, Hiester A, deBoer M, Harbeck RJ, Oyer R, Johnson GL, Roos D) Proc Natl Acad Sci U S A 2000 Apr 25;97(9):4654-9 PMID: 10758162 PMCID: PMC18288 04/12/2000
  • Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis. (Panepinto JA, Magid D, Rewers MJ, Lane PA) J Pediatr 2000 Feb;136(2):201-8 PMID: 10657826 02/05/2000
  • Last update: 08/03/2015